• Catalyst's long-delayed Firdapse snags FDA nod fiercepharma
    December 05, 2018
    It took a breakthrough designation, orphan drug status, an embarrassing up-front rejection letter and some extra trials, but Catalyst Pharmaceuticals has finally crossed the finish line with Firdapse.
PharmaSources Customer Service